These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6641254)

  • 1. Initial aminoglycoside levels in the critically ill.
    Summer WR; Michael JR; Lipsky JJ
    Crit Care Med; 1983 Dec; 11(12):948-50. PubMed ID: 6641254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
    Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D
    South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous arteriovenous hemofiltration of aminoglycoside antibiotics in critically ill patients.
    Zarowitz BJ; Anandan JV; Dumler F; Jayashankar J; Levin N
    J Clin Pharmacol; 1986; 26(8):686-9. PubMed ID: 3793961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
    Dzierzanowska D; Nowik-Jurek M; Podleśny J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
    Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
    Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care.
    Niemiec PW; Allo MD; Miller CF
    Arch Surg; 1987 Feb; 122(2):207-12. PubMed ID: 3813869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia.
    Moore RD; Smith CR; Lietman PS
    Am J Med; 1984 Oct; 77(4):657-62. PubMed ID: 6385693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
    Buchanan AG; Witwicki E; Albritton WL
    Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New schedule for tobramycin administration.
    Lawson RD; Bodey GP; Pan T; Smith TL
    Antimicrob Agents Chemother; 1980 May; 17(5):834-7. PubMed ID: 7396470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.
    Flint LM; Gott J; Short L; Richardson JD; Polk HC
    Arch Surg; 1985 Jan; 120(1):99-103. PubMed ID: 3966875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered aminoglycoside pharmacokinetics in the critically ill.
    Beckhouse MJ; Whyte IM; Byth PL; Napier JC; Smith AJ
    Anaesth Intensive Care; 1988 Nov; 16(4):418-22. PubMed ID: 3232800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.